Adaptive and maladaptive mechanisms of cellular priming

Annals of Surgery

Volumn 226, Issue 5, 1997, Pages 587-598

  Meldrum, Daniel R ^a   Cleveland Jr , Joseph C ^a   Moore, Ernest E ^a   Partrick, David A ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BEPAFANT; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; ENDOTOXIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERCELLULAR ADHESION MOLECULE 1; PHENYLEPHRINE; RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADAPTATION; ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; CELL STIMULATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVIEW; TISSUE INJURY;

ADAPTATION, PHYSIOLOGICAL; CELL PHYSIOLOGY; HUMANS; MACROPHAGES; NEUTROPHILS; REPERFUSION INJURY;

EID: 0031446179     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199711000-00003     Document Type: Review

References (129)

1. Cerra FB. Multiple organ failure syndrome. In: Bihari DJ, Cerra FB, ed. Multiple Organ Failure. Fullerton, CA: Society of Critical Care Medicine, 1989:1-24.
2. Fry DE. Multiple System Organ Failure. St. Louis: Mosby Yearbook, 1992.
3. Fry DE, Pearlstein L, Fulton RL, Polk HC. Multiple system organ failure: the role of uncontrolled infection. Arch Surg 1980; 115:136-140.
4. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983;23:775-787.
5. Eiseman B, Beart R, Norton L. Multiple organ failure. Surg Gynecol Obstet 1977;144:323-326.
6. Shoemaker WC, Apel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 1988;16:1117-1120.
7. Baue AE. The horror autotoxicus and multiple organ failure. Arch Surg 1992;127:1451-1462.
8. Baue AE. Multiple Organ Failure: Patient Care and Prevention. St. Louis: Mosby Yearbook, 1990.
9. Alexander JW, Ogle CK, Stinnett JD. A sequential, prospective analysis of immunologic abnormalities and infection following thermal injury. Ann Surg 1979;188:809-815.
10. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in the adult respiratory distress syndrome. New Horiz 1993;1:538-549.
11. Finkel TH, Pabst MJ, Suzuki H, et al. Priming of neutrophils and macrophage for the enhanced release of Superoxide anion by the calcium ionophore ionomycin: implications for regulation of the respiratory burst. J Biol Chem 1987;262:12589-12596.
12. Murry C, Jennings R, Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
13. Anderson BO, Brown JM, Harken AH. Mechanisms of neutrophil-mediated tissue injury. J Surg Res 1991;51:170-179.
14. Anderson BO, Harken AH. Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 1990;30:S44-S49.
15. Anderson BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991;172:415-424.
16. Biffl WL, Moore EE, Moore FA, et al. IL-6 stimulates neutrophil production of PAF. J Leukocyte Biol 1996;59:569-574.
17. Biffl WL, Moore EE, Moore FA, Barnett CC. IL-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J Leukocyte Biol 1996;58:582-584.
18. Biffl WL, Moore EE, Moore FA, et al. Interleukin 6 delays neutrophil apoptosis. Arch Surg 1996;131:24-30.
19. Botha AJ, Moore FA, Moore EE, Peterson VM. Early neutrophil priming for Superoxide release after injury is via a platelet activating factor mechanism. Br J Surg 1995;82:686.
20. Kim FJ, Moore EE, Moore FA, et al. Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res 1995;58:636-640.
21. Koike K, Moore FA, Moore EE, et al. Endotoxin after gut ischemia-reperfusion causes irreversible lung injury. J Surg Res 1992;52:656-662.
22. Koike K, Moore EE, Moore FA, et al. CD11b blockade prevents lung injury despite neutrophil priming after gut ischemia/reperfusion. J Trauma 1995;39:23-28.
23. Meldrum DR, Harken AH. Platelet activating factor antagonists prevent destructive cellular priming. World J Surg 1996;20:1067-1068.
24. Boulay F, Tardie M, Brouchon L. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein coupled receptors. Biochemistry 1990;29:11123-11133.
25. Forehand JR, Pabst MJ, Phillips WA, Johnston RB. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. J Clin Invest 1989;83:74-83.
26. Meldrum DR, Cleveland JC, Mitchell MB, et al. Constructive priming of myocardium against ischemia-reperfusion injury. Shock 1996;6:238-242.
27. Ayala A, Perrin MM, Wang P, Ertel W, Chaudry IH. Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. J Immunol 1991;147:4147-4154.
28. Brown JM, Grosso MA, Terada LS, et al. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Nat Acad Sci 1989;86:2516-2520.
29. Brown JM, White CW, Terada LS, et al. lnterleukin-1 pretreatment decreases ischemia/reperfusion injury. Proc Nat Acad Sci 1990;87:5026-5030.
30. Brown JM, Anderson BO, Repine J, et al. Neutrophils contribute to TNF-induced myocardial tolerance to ischemia. J Mol Cell Cardiol 1992;24:485-495.
31. Brown JM, Grosso MA, Terada LS, Banerjee A, Harken AH. Endotoxin induces in vivo myocyte HSP-70 expression and protection from cardiac ischemic injury. J Cell Biochem 1993;195:17D.
32. Banerjee A, Locke-Winter C, Rogers KB, et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ Res 1993;73:656-670.
33. Meldrum DR, Mitchell MB, Banerjee A, Harken AH. Cardiac preconditioning: induction of endogenous tolerance to ischemia-reperfusion injury. Arch Surg 1993;128:1208-1211.
34. ++ induced cardioadaptation to ischemia-reperfusion injury. Am J Physiol 1996;271:R1718-R1726.
35. Meldrum DR, Sheridan BC, Cleveland JC, et al. Neutrophil induction is required for endotoxin-mediated myocardial cross-tolerance to ischemia-reperfusion injury. Arch Surg 1996;131:1203-1208.
36. Meldrum DR, Cleveland JC, Sheridan BC, et al. Cardiac preconditioning with calcium: clinically accessible myocardial protection. J Thorac Cardiovasc Surg 1996;112:778-786.
37. Meldrum DR, Harken AH. Preconditioning of skeletal muscle: application to dynamic cardiomyoplasty. J Card Surg 1996; 11:109-110.
38. Meldrum DR, Cleveland JC, Sheridan BC, et al. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 1996;61:1273-1280.
39. Meldrum DR, Cleveland JC, Rowland RT, Banerjee A, Harken AH. Calcium-induced inotropy is in part mediated by protein kinase C. J Surg Res 1996;63:400-405.
40. Poggetti RS, Moore EE, Moore FA, et al. Gut and liver coordinated metabolic response following major torso injury. J Surg Res 1992;52:27-33.
41. Friese RS, Rehring TF, Wollmering M, et al. Trauma primes cells: Editorial review. Shock 1994;1:388-394.
42. Brew EB, Mitchell MB, Rehring TF, et al. The role of bradykinin in cardiac functional protection after global ischemia-reperfusion in the rat heart. Am J Physiol 1995;269:H1370-H1378.
43. Banerjee A, Grosso MA, Rogers KB, Brown JM, Whitman GJR. Oxygen metabolite effects on creatine kinase and cardiac energetics after reperfusion. Am J Physiol 1991;261:H590-H597.
44. Bensard DB, Brown JM, Anderson BO, et al. Induction of endogenous tissue antioxidant enzyme activity attenuates myocardial reperfusion injury. J Surg Res 1990;49(2):126-131.
45. Cairns CB, Bensard DB, Winter CB, Harken AH, Banerjee A. A rapid effect of endotoxin on the myocardium. Surg Forum 1992;43:22-24.
46. Cleveland JC, Meldrum DR, Rowland RT, Banerjee A, Harken AH. Optimal myocardial preservation: cooling, cardioplegia and conditioning. Ann Thorac Surg 1996;61:760-768.
47. Cleveland JC, Meldrum DR, Rowland RT, et al. The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery 1996;120:345-353.
48. Cleveland JC, Woldmering M, Meldrum DR, et al. Ischemic preconditioning in human and rat ventricle. Am J Physiol 1996;271:H1786-H1794.
49. Meng X, Brown JM, Ao L, et al. Heat shock protein 70 contributes to the induced cardiac resistance to bacterial lipopolysaccharide in the rat. Am J Physiol 1996;271:C1316-C1324.
50. Nelson DW, Brown JM, Banerjee A, et al. Pretreatment with a nontoxic derivative of endotoxin (MPL) induces functional protection against cardiac ischemia reperfusion injury. Surgery 1991; 110:365-369.
51. Rowland RT, Cleveland JC, Meng X, et al. A single endotoxin challenge induces delayed myocardial protection against infarction. J Surg Res 1996;63:193-198.
52. Rehring TF, Friese RS, Cleveland JC, et al. Alpha-adrenergic preservation of myocardial pH during ischemia is PKC isoform dependent. J Surg Res 1996;63:324-327.
53. Thornton J, Striplin S, Liu GS, et al. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990;259:H1822-H1825.
54. 1 selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-665.
55. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res 1993;72:112-125.
56. Zucchi R, Ronca-Testoni S, Gongyuan Y, et al. Postischemic changes in cardiac sarcoplasmic reticulum calcium channels: a possible mechanism of ischemic preconditioning. Circ Res 1995;76:1049-1056.
57. Mitchell MB, Meng X, Parker CG, et al. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
58. Berridge MJ. Inositol triphosphate and calcium signalling. Nature 1993;361:315-325.
59. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-613.
60. Ruffolo RR, Nichols AJ. Recent experimental and conceptual advances in drug receptor research in the cardiovascular system. Adv Drug Res 1988;17:237-247.
61. 3. J Leukocyte Biol 1996;59:555-561.
62. Tonetti DA, Henning-Chubb C, Yamanishi DT. Protein kinase C-b is required for macrophage differentiation of human HL-60 leukemia cells. J Biol Chem 1994;269:23230-23235.
63. 2+ATPase. Proc Natl Acad Sci 1990;87:2466-2470.
64. Walker DM, Yellon DM. Ischemic preconditioning: from mechanisms to exploitation. Cardiovasc Res 1992;26:734-739.
65. Zhou X, Zhai X, Ashraf M. Preconditioning of bovine endothelial cells. Circ Res 1996;78:73-81.
66. Nauseef WN, Volpp BD, McCormick S, Leidal KG, Clark RA. Assembly of the neutrophil respiratory burst oxidase: protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J Biol Chem 1991;266:5911-5917.
67. Kahn RA, Yucel JK, Malhotra V. ARF signalling: a potential role for phospholipase D in membrane traffic. Cell 1993;75:1045-1048.
68. Franciose RJ, Moore EE, Moore FA, et al. Hypoxia/reoxygenation of human endothelium activates PMNs to detach via a PAK mechanism. J Surg Res 1996;61:459-462.
69. Gerner EW, Schneider MJ. Induced thermal resistance in HeLa cells. Nature 1975;256:500-502.
70. Currie RW, White FP. Trauma-induced protein in rat tissues: a physiological role for a "heat shock" protein? Science 1981;214:72-75.
71. White FP, White SR. Isoproterenol-induced myocardial necrosis is associated with stress protein synthesis in rat heart and thoracic aorta. Cardiovase Res 1986;20:512-518.
72. Li GC, Werb Z. Correlation between the synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc Natl Acad Sci USA 1982;79:3218-3226.
73. Maulik N, Watanabe M, Engelman D. et al. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol 1995;269:C907-C916.
74. Kloner RA, Shook T. Previous angina alters in-hospital outcome in TIMI-4: a clinical correlate to preconditioning. Circulation 1995;91(1):37-45.
75. Steenbergen C, Fralix T, Murphy E. Role of increased cytosolic calcium concentration in myocardial ischemic injury. Basic Res Cardiol 1993;88:456-470.
76. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infaret size. Circulation 1995;91:291-297.
77. Andreotti F, Pasceri V, Hackett DR, et al. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996;334:7-12.
78. Kim EJ, Moore EE, Moore FA, et al. Disparate signal transduction in neutrophil CD18 adhesion receptor expression versus superoxide generation. Surgery 1994;116:262-267.
79. Moore FA, Moore EE, Ammons LA, McCroskey BL, Presumptive antibiotics for penetrating abdominal wounds. Surg Gynecol Obstet 1989;169:99-104.
80. 2 restores energetics and decreases lethality. J Surg Res 1994;57:55-61.
81. Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996;270:R927-R938.
82. Ayala A, Kisala JM, Felt JA, Perrin MM, Chaudry IH. Does endotoxin tolerance prevent the release of inflammatory mono-kines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis? Arch Surg 1992;127:191-197.
83. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry TH. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators. Circ Shock 1992; 36:191-199.
84. Ayala A, Ertel W, Chaudry IH. Trauma-induced suppression of antigen presentation and expression of major histompatibility class II antigen complex in leukocytes. Shock 1996;5:79-90.
85. Hutter MM, Sievers RE, Barbosa V, Wolfe CL. Heat shock protein induction in rat hearts. A direct correlation between the amount of heat shock protein induced and the degree of myocardial protection. Circulation 1994;89:355-362.
86. Plumier JL, Ross BM, Currie RW, et al. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1995;95:1854-1860.
87. 2. Am J Physiol 1991;261:R351-357.
88. Meldrum DR, Ayala A, Perrin MM, Ertel W, Chaudry IH. Diltiazein restores IL-2, IL-3, IL-6, and IFN-gamma synthesis and decreases host susceptibility to sepsis following hemorrhage. J Surg Res 1991;51:158-164.
89. Meldrum DR, Ayala A, Chaudry IH. Mechanism of diltiazem's immunoprotective effects following hemorrhage and resuscitation. Am J Physiol 1993;265:C412-C421.
90. Baggiolini M, Boulay F, Badwey JA, Curnutte JT. Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J 1993;7:1004-1010.
91. DelBouno BJ, Simons ER. Role of the plasma membrane in signal transduction in human polymorphonuclear leukocytes. J Cell Physiol 1993;154:80-91.
92. Krause KH, Schlegel W, Wollheim CB. Chemotactic peptide activation of human neutrophils and HL-60: pertussis toxin reveals correlation between inositol triphosphate. J Clin Invest 1985; 76:1348-1354.
93. Barnett CC, Moore EE, Moore FA, et al. Intercellular adhesion molecule-1 promotes neutrophil-mediated cytotoxicity. Surgery 1995;118:171-176.
94. Ayala A, Meldrum DR, Perrin MM, Chaudry IH. The release of transforming growth factor beta following hemorrhage: its role as a mediator of host immunosuppression. Immunology 1993;79:479484.
95. Chaudry IH. Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983;245:R117-R134.
96. Chaudry IH, Ayala A, Ertel W, Stephan RN. Hemorrhage and resuscitation; immunological aspects [editorial review]. Am J Physiol 1990;259:R663-R678.
97. 31P-NMR. Surgery 1992;112:150-158.
98. Ertel W, Meldrum DR, Morrison MH, Ayala A, Chaudry IH. Immunoprotective effect of a calcium channel blocker on macrophage antigen presentation function, Ia expression, and IL-1 synthesis following hemorrhage. Surgery 1990;108:154-160.
99. Ertel W, Morrison MH, Meldrum DR, Ayala A, Chaudry IH. Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 1992;53:55-61.
100. Wang P, Chaudry IH. Crystalloid resuscitation restores but does not maintain cardiac output following severe hemorrhage. J Surg Res 1991;50:163-169.
101. Wang P, Ba Z, Meldrum DR, Chaudry IH. Diltiazem restores cardiac output and improves renal function following hemorrhage and resuscitation. Am J Physiol 1992;266:H1435-H1440.
102. Wang P, Ba Z, Burkhardt J, Chaudry IH. Measurement of hepatic blood flow after severe hemorrhage: lack of restoration despite adequate resuscitation. Am J Physiol 1992;262:G92-G98.
103. Kisala JM, Ayala A, Stephan RN, Chaudry IH. A model of pulmonary atelectasis in rats: activation of alveolar macrophage and cytokine release. Am J Physiol 1993;264:R610-R614.
104. Metchnikoff E. Sur la lutte des cellules de l'organisme contre l'invasion des microbes. Ann Inst Pasteur 1887;1:321-326.
105. Ingraham LM, Lafuze JE, Boxer LA, Baehner RL. In vitro and in vivo effects of treatment by platelet activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leukocytes. Br J Haematol 1987;66:219-225.
106. Koenderman L, Tool A, Roos D, Verhoeven AJ. Diacylglycerol accumulation in human neutrophils does not correlate with respiratory burst. FEBS Lett 1989;243:399-403.
107. Koenderman L, Yazdandaksh M, Roos D, Verhoeven AJ. Dual mechanisms in priming of the chemoattractant-induced respiratory burst in human granulocytes: a calcium dependent and independent route. J Immunol 1989;142:623-628.
108. Walker BA, Hagenlocker BE, Ward PA. Superoxide response to formal-methionyl-leucyl-phenylalanine in primed neturophils. Role of intracellular and extracellular calcium. J Immunol 1991;146:3124-3131.
109. Vercelotti GM, Yin HQ, Gustafson KS, Nelson RD, Jacob HS. Platelet activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediaied endothelial damage. Blood 1988;71:1100-1107.
110. Sheridan BC, McIntyre RC, Meldrum DR, et al. Antibody-mediated neutrophil depletion preserves pulmonary vasomotor function. J Surg Res 1996;62:74-78.
111. Agwu DE, McPhail LC, Sozzani S, Bass DA, McCall CE. Phos phatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J Clin Invest 1991;88:531-539.
112. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
113. O'Flaherty JT, Rossi AG, Redman JF, Jacobson DP. Tumor necrosis factor alpha regulates expression of receptors for formyl-methionyl-leucyl-phenylalanine, leukotriene B4, and platelet activating factor. J Imnumol 1991;147:3842-3847.
114. Norgauer J, Eberle M, Fay SP, Lemke HD, Sklar LA. Kinetics of N-formyl peptide up-regulation during stimulation in human neutrophils. J Immunol 1991;146:975-980.
115. Weiss SJ, Lambert MB, Test ST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983;222:625-628.
116. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
117. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 1995;268:H2063-H2067.
118. Vedder NB, Winn RK, Rice CL. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988;81:939-944.
119. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992;216:117-134.
120. Demling R, LaLonde C, Saldinger P. Multiple organ dysfunction in the surgical patient: pathophysiology, prevention and treatment. Curr Probl Surg 1993;30:347-414.
121. Tanaka H, Ogura H, Yokota J, et al. Acceleration of superoxide production from leukocytes in trauma patients. Ann Surg 1991;214:187-192.
122. Shaked G, Alkan M, Nagauker O, Charuzi I, Levy R. Superoxide production by neutrophils from trauma patients: regulation of NADPH oxidase activity. J Trauma 1994;37:22-29.
123. Pape HC, Auf' m' Kolk M, Palffrath T, et al. Primary intramedullary femur fixation in multiple trauma patients with associated pulmonary contusion: a cause of post-traumatic ARDS. J Trauma 1993;34:540-548.
124. Partrick DA, Moore FA, Moore EE, Barnett CC, Silliman CC. Neutrophil priming and activation in the pathogenesis of multiple organ failure. New Horiz 1996;4:194-210.
125. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990;265:17381-17384.
126. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829-1835.
127. Hoch RC, Rodriguez R, Manning T. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993;21:839-845.
128. Deitch E, Bridges W, Ma L, et al. Hemorrhagic shock-induced bacterial translocation: the role of neutrophils and hydroxyl radicals. J Trauma 1990;30:942-947.
129. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophilendothelial cell adhesion in inflammatory disorders. J Crit Care 1994;9:47-71.